Who has invested in D&D Pharmatech?

Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network are named among the investors backing D&D Pharmatech.

D&D Pharmatech Funding: $190M Raised, IPO (2024)

D&D Pharmatech funding overview

D&D Pharmatech has raised $190M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in May 2024. The round record for D&D Pharmatech runs through 2024; nothing later has been disclosed. Investors on record include Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network. 5 distinct backers are named across the disclosed rounds.

D&D Pharmatech at a glance

Total raised: $190M
Latest round: IPO
Latest round date: May 2024
Notable investors: Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network

Frequently asked about D&D Pharmatech funding

How much has D&D Pharmatech raised?: D&D Pharmatech has raised $190M in total disclosed funding across the rounds on record.
Who has invested in D&D Pharmatech?: Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network are named among the investors backing D&D Pharmatech.
What was the latest D&D Pharmatech funding round?: The most recent disclosed round is an IPO, announced in May 2024.
Where is D&D Pharmatech based?: No headquarters location is disclosed for D&D Pharmatech.
When did D&D Pharmatech last raise?: The last disclosed D&D Pharmatech round closed in May 2024 at IPO.

Totals shown for D&D Pharmatech aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

D&D Pharmatech Funding: $190M Raised, IPO (2024)

D&D Pharmatech funding overview

D&D Pharmatech at a glance

Frequently asked about D&D Pharmatech funding

Companies related to D&D Pharmatech (40)

Browse related funding lists (5)